Apellis Pharmaceuticals Inc (APLS)
27.73
+0.24
(+0.87%)
USD |
NASDAQ |
Nov 21, 16:00
27.73
0.00 (0.00%)
After-Hours: 16:47
Apellis Pharmaceuticals Market Cap: 3.449B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 3.420B |
| November 19, 2024 | 3.606B |
| November 18, 2024 | 3.257B |
| November 15, 2024 | 3.268B |
| November 14, 2024 | 3.490B |
| November 13, 2024 | 3.514B |
| November 12, 2024 | 3.640B |
| November 11, 2024 | 3.680B |
| November 08, 2024 | 3.729B |
| November 07, 2024 | 3.575B |
| November 06, 2024 | 3.586B |
| November 05, 2024 | 3.492B |
| November 04, 2024 | 3.553B |
| November 01, 2024 | 3.481B |
| October 31, 2024 | 3.391B |
| October 30, 2024 | 3.447B |
| October 29, 2024 | 3.410B |
| October 28, 2024 | 3.337B |
| October 25, 2024 | 3.257B |
| October 24, 2024 | 3.367B |
| October 23, 2024 | 3.293B |
| October 22, 2024 | 3.369B |
| October 21, 2024 | 3.281B |
| October 18, 2024 | 3.418B |
| October 17, 2024 | 3.408B |
| Date | Value |
|---|---|
| October 16, 2024 | 3.412B |
| October 15, 2024 | 3.412B |
| October 14, 2024 | 3.342B |
| October 11, 2024 | 3.313B |
| October 10, 2024 | 3.256B |
| October 09, 2024 | 3.284B |
| October 08, 2024 | 3.345B |
| October 07, 2024 | 3.351B |
| October 04, 2024 | 3.358B |
| October 03, 2024 | 3.425B |
| October 02, 2024 | 3.477B |
| October 01, 2024 | 3.386B |
| September 30, 2024 | 3.520B |
| September 27, 2024 | 3.588B |
| September 26, 2024 | 3.635B |
| September 25, 2024 | 3.725B |
| September 24, 2024 | 3.744B |
| September 23, 2024 | 3.984B |
| September 20, 2024 | 3.959B |
| September 19, 2024 | 4.472B |
| September 18, 2024 | 4.339B |
| September 17, 2024 | 4.326B |
| September 16, 2024 | 4.421B |
| September 13, 2024 | 4.581B |
| September 12, 2024 | 4.479B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.349B
Minimum
Mar 17 2020
10.87B
Maximum
Jun 13 2023
4.811B
Average
4.604B
Median
Dec 29 2021
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.09B |
| Ionis Pharmaceuticals Inc | 5.360B |
| EyePoint Pharmaceuticals Inc | 569.55M |
| Cassava Sciences Inc | 1.549B |
| Macrogenics Inc | 201.16M |
Market Cap Related Metrics
| PS Ratio | 4.772 |
| Price to Book Value | 14.55 |
| Price | 27.73 |
| Earnings Yield | -7.32% |